Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Aveanna Healthcare Holdings, Inc. reported three-month period ended January 3, 2026 results: revenue $662.5 million, net income $178.8 million, EPS $0.80 per diluted share. Guidance reaffirmed.
- Period
- three-month period ended January 3, 2026
- Revenue
- $662.5 million
- Net income
- $178.8 million
- EPS
- $0.80 per diluted share
- Guidance
- reaffirmed
- Result
- reported results
Exact text from the filing
Revenue was $662.5 million for the three-month period ended January 3, 2026, as compared to $519.9 million for the three-month period ended December 28, 2024, an increase of $142.6 million, or 27.4%. The overall increase in revenue was attributable to a $118.5 million increase in PDS segment revenue, a $14.9 million increase in HHH segment revenue, and a $9.2 million increase in MS segment revenue compared to the fourth quarter of 2024. Gross margin was $213.3 million, or 32.2% of revenue, for the three-month period ended January 3, 2026, as compared to $171.7 million, or 33.0% of revenue, for the three-month period ended December 28, 2024, an increase of $41.6 million, or 24.2%. Net income was $178.8 million for the three-month period ended January 3, 2026, as compared to net income of $29.2 million for the three-month period ended December 28, 2024. Net income per diluted share was $0.80 for the three-month period ended January 3, 2026, as compared to net income per diluted share of
View on SEC.gov